Back to 
MORGAN STANLEY
MORGAN STANLEY
AKTX
2 quarters
Position history for MORGAN STANLEY's holdings in AKARI THERAPEUTICS PLC
No. Morgan Stanley exited its AKTX (Akari Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 1 shares worth $5. Morgan Stanley first reported AKTX in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$5
Total Shares Change
-1
Quarter-by-Quarter History